Join to View Full Profile
1800 Orleans StreetBaltimore, MD 21287
Are you Dr. Eshleman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Susan Eshleman, MD is a board certified pathologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland. She is affiliated with Johns Hopkins Hospital and is a Professor of Pathology at Johns Hopkins University School of Medicine;.
Education & Training
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1988 - 1993- University of Pennsylvania Health SystemInternship, Internal Medicine, 1987 - 1988
Perelman School of Medicine at the University of PennsylvaniaClass of 1987
Certifications & Licensure
MD State Medical License 1997 - 2026
American Board of Pathology Clinical Pathology- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- 1 citationsHIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084.Jessica M Fogel, Deborah Persaud, Estelle Piwowar-Manning, Paul Richardson, Joseph Szewczyk
AIDS Research and Human Retroviruses. 2025-01-01 - 4 citationsFeatures of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis.Raphael J Landovitz, Sinead Delany-Moretlwe, Jessica M Fogel, Mark A Marzinke, Estelle Piwowar-Manning
The New England Journal of Medicine. 2024-10-03 - 4 citationsEvaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis.Jessica M Fogel, Estelle Piwowar-Manning, Amber Moser, Tinia Hill, Shahnaz Ahmed
Microbiology Spectrum. 2024-07-09
Press Mentions
HIV Incidence: Effect of Universal Testing and TreatmentJuly 17th, 2019
HIV Status May Be Misreported by People Who Inject DrugsJanuary 14th, 2019- HIV-1 Diversity Among Young Women in Rural South Africa: HPTN 068July 5th, 2018
Grant Support
- LC: HIV PREVENTION TRIALS NETWORKJOHNS HOPKINS UNIVERSITY2006–2027
